Hepatitis E virus (HEV) as an emerging challenge in Poland: a narrative review of epidemiological and clinical data.

IF 3.6 4区医学 Q1 MEDICINE, GENERAL & INTERNAL

Archives of Medical Science Pub Date : 2026-02-15 eCollection Date: 2026-01-01 DOI:10.5114/aoms/214289

Piotr Grabarczyk, Aleksandra Kalińska, Aneta Kopacz, Ewa Sulkowska, Anna Parfieniuk-Kowerda, Jerzy Jaroszewicz

{"title":"Hepatitis E virus (HEV) as an emerging challenge in Poland: a narrative review of epidemiological and clinical data.","authors":"Piotr Grabarczyk, Aleksandra Kalińska, Aneta Kopacz, Ewa Sulkowska, Anna Parfieniuk-Kowerda, Jerzy Jaroszewicz","doi":"10.5114/aoms/214289","DOIUrl":null,"url":null,"abstract":"<p><p>Manuscripts on hepatitis E virus (HEV) epidemiology in Poland indexed in PubMed were analyzed in the context of current clinical and biological knowledge and epidemiological data from other regions of Europe and worldwide. The analyzed data indicate a high frequency of IgG HEV in Poland compared to other European countries and parts of the world, on average exceeding 40%. In some regions, almost 60% of the population has evidence of prior infection. It has been estimated based on the frequency of acute phase markers that at least 113,000 residents may acquire HEV infection annually. These findings support the need to improve availability of HEV diagnostics, increase physicians' awareness, and take into account HEV infection as an etiological factor of numerous diseases. Preventive measures, especially in high-risk groups, as well as further research on the clinical significance of HEV and on effective therapeutic management, should be considered.</p>","PeriodicalId":8278,"journal":{"name":"Archives of Medical Science","volume":"22 3","pages":"1275-1291"},"PeriodicalIF":3.6000,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13426170/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5114/aoms/214289","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Manuscripts on hepatitis E virus (HEV) epidemiology in Poland indexed in PubMed were analyzed in the context of current clinical and biological knowledge and epidemiological data from other regions of Europe and worldwide. The analyzed data indicate a high frequency of IgG HEV in Poland compared to other European countries and parts of the world, on average exceeding 40%. In some regions, almost 60% of the population has evidence of prior infection. It has been estimated based on the frequency of acute phase markers that at least 113,000 residents may acquire HEV infection annually. These findings support the need to improve availability of HEV diagnostics, increase physicians' awareness, and take into account HEV infection as an etiological factor of numerous diseases. Preventive measures, especially in high-risk groups, as well as further research on the clinical significance of HEV and on effective therapeutic management, should be considered.

查看原文本刊更多论文

戊型肝炎病毒（HEV）作为波兰的新挑战：流行病学和临床数据的叙述性回顾

在PubMed检索的关于波兰戊型肝炎病毒（HEV）流行病学的手稿在当前临床和生物学知识以及来自欧洲其他地区和全世界的流行病学数据的背景下进行了分析。分析数据表明，与其他欧洲国家和世界部分地区相比，波兰的IgG HEV频率较高，平均超过40%。在一些区域，几乎60%的人口有先前感染的证据。根据急性期标记物的频率估计，每年至少有113,000名居民可能感染HEV。这些发现支持有必要提高HEV诊断的可获得性，提高医生的认识，并将HEV感染作为许多疾病的病因考虑在内。应考虑采取预防措施，特别是在高危人群中采取预防措施，并进一步研究HEV的临床意义和有效的治疗管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Archives of Medical Science 医学-医学：内科

CiteScore

4.90

自引率

7.90%

发文量

139

审稿时长

1.7 months

期刊介绍： Archives of Medical Science (AMS) publishes high quality original articles and reviews of recognized scientists that deal with all scientific medicine. AMS opens the possibilities for young, capable scientists. The journal would like to give them a chance to have a publication following matter-of-fact, professional review by outstanding, famous medical scientists. Thanks to that they will have an opportunity to present their study results and/or receive useful advice about the mistakes they have made so far. The second equally important aim is a presentation of review manuscripts of recognized scientists about the educational capacity, in order that young scientists, often at the beginning of their scientific carrier, could constantly deepen their medical knowledge and be up-to-date with current guidelines and trends in world-wide medicine. The fact that our educational articles are written by world-famous scientists determines their innovation and the highest quality.